Inventor · disambiguated record
Henning Thøgersen
Also filed as: THOEGERSEN HENNING · THØGERSEN HENNING
8 granted patents·5 pending applications·161 citations·filing 2000–2024
86Inventor score
Top patents by PatentIndex Score
13 records- 0195US6875760B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2002·Granted Apr 5, 2005·56 cites·80 claims
- 0295US6503949B1Glucagon antagonists/inverse agonistsNORO NORDISK AS·Filed 2000·Granted Jan 7, 2003·67 cites·56 claims
- 0390US8895694B2Glucagon-Like Peptide-1 derivatives and their pharmaceutical useSPETZLER JANE·Filed 2008·Granted Nov 25, 2014·29 cites·11 claims
- 0478US8895504B2Amylin derivativesSCHÄFFER LAUGE·Filed 2009·Granted Nov 25, 2014·7 cites·11 claims
- 0576US12226487B2Therapeutic derivatives of interleukin-22CYTOKI PHARMA APS·Filed 2024·Granted Feb 18, 2025·0 cites·6 claims
- 0674US12447211B2Therapeutic derivatives of interleukin-22CYTOKI PHARMA APS·Filed 2023·Granted Oct 21, 2025·0 cites·15 claims
- 0772US11806403B2Therapeutic derivatives of interleukin-22CYTOKI PHARMA APS·Filed 2022·Granted Nov 7, 2023·0 cites·96 claims
- 0865US9480753B2FGF21 derivatives with albumin binder A-B-C-D-E- and their useTAGMOSE TINA MØLLER·Filed 2010·Granted Nov 1, 2016·2 cites·10 claims
- 0958US2010292133A1Truncated glp-1 derivaties and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1058US2010261637A1Peptides derivatized with a-b-c-d- and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1157US2024279297A1Therapeutic derivatives of interleukin-22CYTOKI PHARMA APS·Filed 2022·Application pending·0 cites
- 1257US2024239855A1Therapeutic derivatives of interleukin-22CYTOKI PHARMA APS·Filed 2022·Application pending·0 cites
- 1332US2012035099A1Fgf21 analogues and derivativesGARIBAY WILLIAM PATRICK·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henning Thøgersen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →